TMPRSS11B: A Protein Target for Cancer and Neurodegenerative Diseases

Target Name: TMPRSS11B

NCBI ID: G132724

TMPRSS11B

TMPRSS11B: A Protein Target for Cancer and Neurodegenerative Diseases

TMPRSS11B (Transmembrane Protease, Serine 11B) is a protein that is expressed in a variety of tissues throughout the body, including the brain, pancreas, and heart. It is a member of the Tmembrane protein family, which is known for their involvement in cell signaling and membrane transport. TMPRSS11B is involved in the regulation of a variety of cellular processes, including cell adhesion, migration, and signaling pathways.

TMPRSS11B has also been shown to play a role in the development and progression of certain diseases, including cancer. For example, studies have shown that high levels of TMPRSS11B are associated with poor prognosis in pancreatic cancer. Additionally, TMPRSS11B has been implicated in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Due to its involvement in these processes, TMPRSS11B has been identified as a potential drug target. Researchers are currently working to develop small molecules that can inhibit TMPRSS11B activity and prevent or reverse the negative effects of this protein on disease. These small molecules may be used to treat a variety of diseases, including cancer, neurodegenerative diseases, and other conditions that are characterized by the over-expression or under-expression of TMPRSS11B.

In addition to its potential as a drug target, TMPRSS11B is also being investigated as a biomarker. The ability to detect and measure the levels of TMPRSS11B in a patient's body has the potential to improve the accuracy and effectiveness of diagnostic tests. For example, studies have shown that the levels of TMPRSS11B in the blood are significantly increased in individuals with pancreatic cancer, which could be used as a diagnostic marker for this disease.

TMPRSS11B is also being studied as a potential therapeutic target in other contexts. For example, researchers are exploring the use of small molecules to inhibit TMPRSS11B activity in the brain and treat conditions such as Alzheimer's disease and Parkinson's disease. Additionally, TMPRSS11B has been shown to play a role in the regulation of ion channels in muscle cells, which could make it a potential target for muscle-related diseases.

In conclusion, TMPRSS11B is a protein that is involved in a variety of cellular processes throughout the body. Its involvement in disease development and progression makes it a potential drug target and biomarker. As research continues to advance, the potential uses for TMPRSS11B will continue to emerge.

Protein Name: Transmembrane Serine Protease 11B

Functions: Serine protease

The "TMPRSS11B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMPRSS11B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets